中文 English

Drug Product CDMO Services

Synergizing with Small Molecule API and Intermediates CDMO Services

Drug Product CDMO Services

Solubility Enhancement Technology

To address new chemical entities with low solubility, estimated to represent 40 - 90% of all new drugs, Solubility enhancement and Solid dispersion related technologies will be widely used in drug development and manufacturing. Porton utilizes crystallization, particle engineering, solid dispersion related technologies, to provide the solutions to the low solubility drugs development for our customers.

Wechat sharing X
Open wechat scan
and share with friends

Legal Notices About Porton Investor Relations

Fangzheng Avenue, Shuitu, Beibei District, Chongqing, China.

Copyright © 2020 Porton Group. DIGITAL BY VTHINK


渝公网安备 50010902001378号